For instance, in cases of ovarian cancer, patients whose cancer cells showed higher FRα expression experienced a poor response to chemotherapy, as evidenced by an OR of 8.97 (95% CI: 1.40–57.36, p = 0.021) [54]. This evidence concerns the gene FOLR1 and ovarian cancer.